Skip to content


Open Access

Patient readmission for surgical wound infection

  • LM Torres1,
  • RA Lacerda2 and
  • R Turrini2
BMC Proceedings20115(Suppl 6):P192

Published: 29 June 2011


Staphylococcus AureusTertiary CareAntibiotic ProphylaxisSuccessful ProgramPost Discharge

Introduction / objectives

Surgical site infection (SSI) rates are underestimated mainly in the absence of a successful program of post discharge surveillance. Readmissions monitoring can contribute to accurate infection rates.


Exploratory descriptive study, developed in a governmental hospital of tertiary care in Minas Gerais (Brazil), from January 2008 to December 2009. Medical records and reports of control infection practitioner of 98 patients readmitted with SSI were reviewed and the data were analyzed in relation to gender, age, co morbidities, length of staying, surgery, specialty, type of procedures, wound class, duration of surgery, SSI and micro-organisms.


Readmissions occurred in patients who underwent clean and potentially contaminated surgical procedures, with co morbidities commonly among people 50 years or older. Duration of surgery did not differ from the cut point recommended by CDC. Staphylococcus aureus predominated in orthopedic procedures and Escherichia coli in general surgery, both with multi-resistance profile below the results presented in other studies.


Whereas the SSI occurred more frequently in clean surgeries and readmissions can provide information about the quality of care, these findings are important to control infection practitioner review the antibiotic prophylaxis protocols and surgical practices in patients undergoing clean and potentially contaminated procedures.

Disclosure of interest

None declared.

Authors’ Affiliations

Enfermagem Médico-Cirúrgica, Escola de Enfermagem da Universidade de São Paulo, Nova Lima, Brazil
Enfermagem Médico-Cirúrgica, Escola de Enfermagem da Universidade de São Paulo, São Paulo, Brazil


© Torres et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.